Col4a5-R471X
Nomenclature
C57BL/6Smoc-Col4a5em1(R471X)Smoc
Cat. NO.
NM-KI-200183
Strain State
Repository Live
Gene Summary
Gene Symbol
Col4a5
Model Description
Validation Data
Fig 1. Col4a5 mRNA level was measured in Col4a5-R471X mice (n=3, male, 6 week-old) and the point mutation of Col4a5 has been verified by sequencing.
Abbr. HO, homozygous; WT, wild type.
Fig 2. The results of urine (A) and blood (B) biochemical indicators in Col4a5-R471X mice (n=2 male and 6 female).
Abbr. WT, wild type.
Fig 3. The results of urine (A) and plasma (B) biochemical indicators in 21-weeks-old Col4a5-R471X mice (n=3/group).(Data from a cooperator)
Abbr. WT, wild type.
Fig 4. Marked glomerular changes are recognized in all (8/8) R471X mice of 23 weeks of age.
The renal cortex shows uniform glomerular distribution, with mesangial matrix proliferation and mild sclerosis (yellow arrow). Renal tubular changes include epithelial edema (blue arrow), atrophy (orange arrow), dilation (green arrow), and necrosis (black arrow). Connective tissue proliferation (light green arrow), lymphocyte infiltration (purple arrow), and occasional protein casts (gray arrow) are noted. Such lesions are entirely absent in controls of same age. Scale bar=100 μm; magnification, 200×.
Abbr. WT, wild type.
Fig 5. Effects of Ramipril (10mg/kg) on urine (A) and blood (B) biochemical indicators of Col4a5-R471X mice over a 16-17 weeks treatment period (6 weeks of age at initiation time, n=4-5 male and 4-5 female in each group).
Abbr. WT, wild type.
Fig 6. Effects of Ramipril (10mg/kg) on urine (A) and plasma (B) biochemical indicators of male and female Col4a5-R471X mice over a 16-17 weeks treatment period respectively (6 weeks of age at initiation time, n=4-5 male and 4-5 female in each group).
Abbr. WT, wild type.
Fig 7. Body weight (A) and serum mCystain C (B) of Col4a5-R471X mice over a 17 weeks treatment period (6 weeks of age at initiation time, n=4-5 male and 4-5 female in each group).
Abbr. WT, wild type.
Fig 8. Histopathology changes of Col4a5-R471X mice over a 17 weeks treatment period (6 weeks of age at initiation time, n=4-5 male and 4-5 female in each group). Data are presented as mean and ± SEM
Abbr. WT, wild type.
You may also like
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
Learn moreAt GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.
Learn more
